MOHAP Pharmacist Exam study materials
MOHAP Pharmacist Exam study resources

MOHAP Pharmacist Exam cheat sheet

MOHAP Pharmacist Exam · Keep the key ideas within reach.

Quick reference

Pharmacy Practice and Pharmaceutical Care

  • Pharmaceutical care is the responsible provision of drug therapy to achieve definite outcomes that improve a patient's quality of life; it requires a direct pharmacist-patient relationship.

  • The pharmaceutical care process has three core steps: assessment (identify and prioritize drug therapy problems), care plan development, and evaluation/follow-up.

  • Seven categories of drug therapy problems: unnecessary drug therapy, needs additional therapy, ineffective drug, dose too high, dose too low, adverse drug reaction, and nonadherence.

  • SOAP note format: Subjective (patient-reported symptoms/history), Objective (labs, vitals, exam findings), Assessment (problem list and drug therapy problems), Plan (interventions and monitoring).

  • Medication reconciliation is performed at every transition of care (admission, transfer, discharge) and compares the best possible medication history against current orders.

  • Adherence measurement methods: pill counts and refill records are indirect/objective; patient interview is indirect/subjective; directly observed therapy is the most reliable.

  • A medication error is any preventable event that may cause or lead to inappropriate medication use or patient harm; it is distinct from an adverse drug reaction, which is not preventable by definition.

  • The Pharmacists' Patient Care Process (PPCP) has five steps: collect, assess, plan, implement, and monitor/evaluate.

Quick reference

Pharmacology and Pharmacotherapeutics

  • Beta-1 selective blockers (e.g., metoprolol, bisoprolol) reduce mortality in heart failure; nonselective agents are avoided because they block beta-2-mediated vasodilation.

  • ACE inhibitors cause cough via bradykinin accumulation and hyperkalemia via reduced aldosterone; they are contraindicated in pregnancy and bilateral renal artery stenosis.

  • Warfarin inhibits vitamin K epoxide reductase (VKORC1), reducing factors II, VII, IX, X; effect is monitored by INR, and vitamin K reverses it.

  • Heparin potentiates antithrombin III, inhibiting thrombin and factor Xa; effect is monitored by aPTT and reversed by protamine sulfate.

  • Aminoglycosides bind the bacterial 30S ribosomal subunit, are bactericidal, and are nephrotoxic and ototoxic; they require renal dose adjustment and therapeutic drug monitoring.

  • Macrolides and fluoroquinolones prolong the QT interval; combining them with other QT-prolonging drugs increases the risk of torsades de pointes.

  • Metformin is first-line for type 2 diabetes; it decreases hepatic gluconeogenesis and is contraindicated in severe renal impairment (eGFR <30) due to lactic acidosis risk.

  • Levothyroxine is taken on an empty stomach 30-60 minutes before breakfast; calcium, iron, and PPIs reduce its absorption.

Quick reference

Pharmaceutical Sciences (Pharmaceutics, Medicinal Chemistry, Pharmacognosy)

  • First-order elimination: rate is proportional to plasma concentration; half-life t1/2 = 0.693 × Vd / CL, and steady state is reached after approximately 4-5 half-lives.

  • Bioavailability F = (AUCoral × DoseIV) / (AUCIV × Doseoral); for an IV dose, F is 100% by definition.

  • Zero-order kinetics (saturation) means a constant amount is eliminated per unit time regardless of concentration; small dose increases can cause disproportionate rises in plasma levels (e.g., phenytoin, ethanol).

  • The Henderson-Hasselbalch equation: pH = pKa + log([A-]/[HA]) for acids; drug ionization determines lipid membrane permeability and urinary reabsorption.

  • A prodrug is an inactive derivative that must be biotransformed to release the active drug (e.g., enalapril to enalaprilat); it improves absorption or targeting.

  • Phase I metabolism involves oxidation, reduction, and hydrolysis (often CYP450-mediated); Phase II involves conjugation (glucuronidation, sulfation) that increases water solubility for excretion.

  • Excipients include diluents, binders, disintegrants, lubricants, and glidants; they affect tablet hardness, disintegration, and dissolution rate.

  • Pharmacognosy sources: digitalis glycosides from Digitalis purpurea, morphine from Papaver somniferum, and quinine from Cinchona bark.

Quick reference

Pharmacy Law, Ethics and Regulatory Affairs

  • A prescription is valid only when it contains the prescriber's name, signature, date, patient identifiers, drug name, strength, dosage form, directions, and quantity.

  • Controlled substances are classified into schedules based on abuse potential and accepted medical use; Schedule I drugs have no accepted medical use and the highest abuse potential.

  • Narcotic and controlled drug prescriptions have stricter requirements: limited validity period, no refills in many jurisdictions, and mandatory prescriber identification.

  • Pharmacists must maintain prescription records for the legally required retention period (commonly 5 years) and must not dispense on an expired or altered prescription.

  • Ethical principles: autonomy (respect patient choice), beneficence (act in patient's interest), nonmaleficence (do no harm), justice (fair distribution), and confidentiality.

  • Informed consent requires disclosure of the nature of the treatment, risks, benefits, and alternatives, and voluntary patient agreement.

  • Generic substitution is permitted only when the law allows it, the prescriber has not prohibited it, and the patient consents; the substituted product must be bioequivalent.

  • Adverse drug reactions and medication errors must be reported to the national pharmacovigilance authority; serious and unexpected reactions require expedited reporting.

Quick reference

Patient Safety

  • High-alert medications (e.g., insulin, heparin, concentrated electrolytes, chemotherapy) carry a heightened risk of harmful error and require double-checking and standardized labeling.

  • Look-alike/sound-alike drug names (e.g., hydralazine vs. hydroxyzine) are a leading cause of wrong-drug errors; use tall-man lettering and read-back verification.

  • The 'five rights' of medication administration: right patient, right drug, right dose, right route, right time (some add reason and documentation).

  • Root cause analysis is a structured retrospective method for investigating serious adverse events and identifying system-level contributing factors.

  • The Swiss cheese model describes how multiple layers of defense (checks, protocols, technology) each have gaps that can align to allow an error to reach the patient.

  • ISMP error-prone abbreviations to avoid: 'U' for units, 'QD'/'QOD', trailing zeros (e.g., 1.0 mg), and the abbreviation 'MS' (morphine sulfate vs. magnesium sulfate).

  • Medication error reporting systems should be nonpunitive and confidential to encourage reporting; a just culture balances accountability with system improvement.

  • Antimicrobial stewardship programs aim to optimize antimicrobial selection, dose, and duration to improve outcomes and limit resistance and Clostridioides difficile infection.

Quick reference

Quality and Professional Communication

  • The teach-back method confirms patient understanding by asking the patient to restate instructions in their own words rather than asking 'Do you understand?'

  • Health literacy assessment: use plain language, limit information to 3-5 key points, avoid jargon, and supplement verbal counseling with written or pictorial materials.

  • Closed-loop communication in healthcare teams requires a sender, a receiver, and read-back confirmation to prevent miscommunication.

  • SBAR (Situation, Background, Assessment, Recommendation) is a structured handoff communication tool for clinical teams.

  • Quality improvement uses the PDSA cycle (Plan-Do-Study-Act) and measures structure, process, and outcome indicators.

  • Nonverbal communication (eye contact, posture, tone) and active listening (paraphrasing, reflecting) are core components of patient-centered counseling.

  • Documentation of pharmacist interventions should include the problem, intervention, outcome, and follow-up plan to support continuity of care and quality metrics.